Symfo

Symfo, a leading provider of electronic patient reported outcome (ePRO) solutions for clinical trials, reported today that its revenues grew by 44% in 2005.

Over the course of the year, Symfo added new clients and supported different international studies. Highlights of Symfo's record year included the start of a multinational clinical trial taking place in 12 countries throughout the UK, Eastern & Western Europe, South Africa and Israel.

"2005 was a terrific year for Symfo," said Serge Bodart, CEO of Symfo. "The growth we are seeing is directly related to the confidence study sponsors have in Symfo to provide high-quality ePRO data. More and more they are finding the benefit of using our unique IDR system for sending patient data. It's 100% reliable and works anywhere in the world. At the end of the day, what matters most to the study team is that they have the data to work with. With Symfo they get guaranteed results."

2006 promises to be an even a better year, confirming the tremendous development of Symfo and the trust international companies are putting in Symfo's unique technology and its expert team.

About Symfo

Symfo is an international organization specializing in electronic patient diary solutions, including the SymPro electronic patient diary, the SymQuest Palm-based diary and the SymVoice IVR. They are all simple to use and affordable solutions enabling study participants to easily implement electronic patient diaries in all phases of clinical trials and post-marketing studies.

Symfo's FDA-compliant handheld devices (SymPro & SymQuest) utilize Symfo's unique IDR system (Interactive Diary Response) – providing all the advantages of a handheld device (easy to carry, fits in your pocket) combined with simple, reliable phone-based data transfer. Symfo's IDR system guarantees 100% successful transmission of patient data – and works anywhere in the world.

For further details, please visit www.symfo.com.